SS-31 50 mg · Batch SS50-0902
Uther · Janoshik
Test date: 2026-09-18. Purity: 99.740%.
Peptide certificates of analysis
Find published laboratory reports by supplier, substance or batch number. Filter by test type, test date and archive availability to compare the documents behind a batch.
977 matching reports. Browse suppliers
5-Amino-1MQ / MOTS-c / NAD+ · Batch MITO120-0902
Uther · Janoshik
Test date: 2026-09-17. Content: 5-Amino-1-methylquinolinium 11.18 mg NAD+ 138.31 mg MOTS-c 10.58 mg.
GHK-Cu 50 mg · Batch HK50-0902
Uther · Janoshik
Test date: 2026-09-17. Purity: 99.417%.
Tesamorelin 20 mg · Batch TE20-0902
Uther · Janoshik
Test date: 2026-09-17. Purity: 99.178%.
Retatrutide 10 mg · Batch RE10-0901
Uther · Janoshik
Test date: 2026-09-17. Endotoxin: <1 EU/Vial.
Tirzepatide 30 mg · Batch ZE30-0831
Uther · Janoshik
Test date: 2026-09-16. Purity: 99.812%.
Tirzepatide 20 mg · Batch ZE20-0902
Uther · Janoshik
Test date: 2026-09-16. Purity: 99.779%.
Retatrutide 40 mg · Batch RE40-0831
Uther · Janoshik
Test date: 2026-09-16. Purity: 99.677%.
Retatrutide 10 mg · Batch RE10-0901
Uther · Janoshik
Test date: 2026-09-16. Purity: 99.596%; 99.572%; 99.483%.
AHK-Cu 100 mg · Batch AHK100-0822
Uther · Janoshik
Test date: 2026-09-14. Content: AHK-Cu (AHK content) [Copper Content] 99.33 mg (84.78 mg) [14.55 mg].
Pancragon 20 mg · Batch PAN20-0830
Uther · Janoshik
Test date: 2026-09-14. Purity: 98.494%.
GHK-CU/KPV 50/20 · Batch CU50KP20-0827
Uther · Janoshik
Test date: 2026-09-14. Content: GHK-Cu (GHK content) [Copper Content] 61.33 mg (53.82 mg) [7.51 mg] KPV 21.84 mg.
Records link to published sources. A report describes the sample tested; it is not an endorsement of a supplier or a guarantee for other vials.